Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

AxyS initiates phase I studies of APC-2059 for treatment of acute inflammatory bowel disease

Dec. 3, 1998

Lead SelCID compound poised to enter phase II clinical trials for Crohn's disease

Dec. 2, 1998

Health Canada approves lamivudine for treatment of chronic HBV

Dec. 2, 1998

AMBI seeks partners to develop oral nisin for H. pylori eradication

Dec. 2, 1998

Multiple clinical studies support efficacy and safety of HSR-237 in patients with IBS

Nov. 30, 1998

Ferring patents dual T-cell proliferation and protein farnesyltransferase inhibitors

Nov. 27, 1998

Potent and highly selective CCK-A antagonist designed by Tobishi

Nov. 26, 1998

New compounds for immunoinflammatory and neoplastic diseases in the pipeline at Ferring

Nov. 26, 1998

Shearwater Polymers will pegylate interferon alfa-2a for Roche under new agreement

Nov. 26, 1998

Major clinical trials demonstrate efficacy of Rebetron in chronic HCV infection

Nov. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...